HIMSS, ASHHRA to collaborate for health IT training

Jeff Byers | | Health Exec | Economics
Healthcare Information & Management Systems Society (HIMSS) and the American Society for Healthcare Human Resources Administration (ASHHRA) will collaborate to advance health IT workforce initiatives expected to grow in the next several years.

The collaboration will involve HIMSS and ASHHRA sharing links, resources and white papers on the website of each organization, the Chicago-based HIMSS stated.

According to HIMSS, the collaboration with ASHHRA enhances both organizations’ ability to serve the various stakeholders in the health IT career process, from human resources teams to executives who have ties to HIMSS and are looking to fill health IT positions. The collaborative synergistic effort will help further communication between those seeking health IT positions and those seeking qualified health IT applicants, the nonprofit added.

Jeff Byers

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.